Select Medical Financials
SEM Stock | USD 21.03 0.08 0.38% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Return On Equity | 0.2 | 0.189 |
|
| |||||
Operating Income | 378.2 M | 554.9 M |
|
| |||||
Current Ratio | 1.33 | 1.0074 |
|
|
The essential information of the day-to-day investment outlook for Select Medical includes many different criteria found on its balance sheet. An individual investor should monitor Select Medical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Select Medical.
Cash And Equivalents |
|
Select | Select Account or Indicator |
Select Medical Stock Summary
Select Medical competes with Ensign, Encompass Health, InnovAge Holding, Enhabit, and Pennant. Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania. Select Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 35900 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | US81619Q1058 |
CUSIP | 81619Q105 |
Location | Pennsylvania; U.S.A |
Business Address | 4714 Gettysburg Road, |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.selectmedical.com |
Phone | 717 972 1100 |
Currency | USD - US Dollar |
Select Medical Key Financial Ratios
Return On Equity | 0.18 | ||||
Profit Margin | 0.04 % | ||||
Operating Margin | 0.08 % | ||||
Price To Sales | 0.39 X | ||||
Revenue | 6.66 B |
Select Medical Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.3B | 7.7B | 7.4B | 7.7B | 7.7B | 4.9B | |
Other Current Liab | 535.4M | 799.9M | 748.5M | 656.5M | 728.0M | 365.1M | |
Net Debt | 4.2B | 3.9B | 4.6B | 5.0B | 4.9B | 2.8B | |
Retained Earnings | 279.8M | 553.2M | 593.3M | 581.0M | 751.9M | 789.4M | |
Accounts Payable | 145.7M | 177.1M | 233.8M | 186.7M | 174.3M | 131.2M | |
Cash | 335.9M | 577.1M | 74.3M | 97.9M | 84.0M | 110.8M | |
Net Receivables | 762.7M | 896.8M | 889.3M | 941.3M | 940.3M | 597.3M | |
Good Will | 3.4B | 3.4B | 3.4B | 3.5B | 3.5B | 2.5B | |
Other Current Assets | 114.4M | 120.2M | 175.8M | 264.0M | 174.3M | 236.7M | |
Total Liab | 6.4B | 6.4B | 6.0B | 6.3B | 6.1B | 4.1B | |
Total Current Assets | 1.2B | 1.6B | 1.1B | 1.3B | 1.3B | 829.8M | |
Short Term Debt | 233.1M | 453.4M | 289.3M | 311.5M | 344.6M | 361.8M | |
Intangible Assets | 409.1M | 387.5M | 374.9M | 351.7M | 329.9M | 233.3M | |
Other Liab | 249.6M | 301.1M | 249.2M | 275.9M | 317.3M | 200.2M | |
Other Assets | 93.2M | 1.4B | 356.7M | 94.3M | 108.5M | 202.7M | |
Long Term Debt | 3.4B | 3.4B | 3.6B | 3.8B | 3.6B | 2.6B | |
Net Tangible Assets | (2.1B) | (2.3B) | (2.7B) | 804.3M | 723.9M | 760.1M | |
Long Term Debt Total | 3.4B | 3.4B | 3.6B | 3.8B | 4.4B | 2.9B | |
Capital Surpluse | 491.0M | 509.1M | 504.3M | 452.2M | 520.0M | 521.3M |
Select Medical Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 200.6M | 153.0M | 136.0M | 169.1M | 198.6M | 152.3M | |
Total Revenue | 5.5B | 5.5B | 6.2B | 6.3B | 6.7B | 4.2B | |
Gross Profit | 812.9M | 821.3M | 919.4M | 733.4M | 932.0M | 639.3M | |
Operating Income | 471.9M | 567.7M | 713.8M | 403.3M | 554.9M | 378.2M | |
Ebit | 471.9M | 477.6M | 570.1M | 379.5M | 554.9M | 391.0M | |
Ebitda | 709.4M | 683.3M | 772.7M | 585.3M | 763.6M | 526.3M | |
Cost Of Revenue | 4.6B | 4.7B | 5.3B | 5.6B | 5.7B | 3.5B | |
Income Before Tax | 264.7M | 456.5M | 629.7M | 260.6M | 382.4M | 236.2M | |
Net Income | 201.0M | 259.0M | 402.2M | 159.0M | 243.5M | 150.2M | |
Income Tax Expense | 63.7M | 111.9M | 129.8M | 62.6M | 82.6M | 62.9M | |
Minority Interest | 52.6M | 85.6M | 97.7M | (39.0M) | (56.2M) | (53.4M) | |
Tax Provision | 63.7M | 111.9M | 129.8M | 62.6M | 82.6M | 75.6M | |
Interest Income | 176.6M | 175.6M | 123.6M | 5.4M | 142.7M | 0.0 | |
Net Interest Income | (200.6M) | (153.0M) | (130.6M) | (169.1M) | (198.6M) | (208.6M) |
Select Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Select Medical's current stock value. Our valuation model uses many indicators to compare Select Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Select Medical competition to find correlations between indicators driving Select Medical's intrinsic value. More Info.Select Medical Holdings is rated second in return on equity category among its peers. It is rated fourth in return on asset category among its peers reporting about 0.26 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Select Medical Holdings is roughly 3.81 . At this time, Select Medical's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Select Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Select Medical Holdings Systematic Risk
Select Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Select Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Beta measures systematic risk based on how returns on Select Medical Holdings correlated with the market. If Beta is less than 0 Select Medical generally moves in the opposite direction as compared to the market. If Select Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Select Medical Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Select Medical is generally in the same direction as the market. If Beta > 1 Select Medical moves generally in the same direction as, but more than the movement of the benchmark.
Select Medical Thematic Clasifications
Select Medical Holdings is part of several thematic ideas from Healthcare to Baby Boomer Prospects. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasToday, most investors in Select Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Select Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Select Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Select Medical December 3, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Select Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Select Medical Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Select Medical Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Select Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Select Medical's daily price indicators and compare them against related drivers.
Downside Deviation | 1.99 | |||
Information Ratio | 0.0147 | |||
Maximum Drawdown | 16.75 | |||
Value At Risk | (2.51) | |||
Potential Upside | 3.01 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.139 | Dividend Share 0.5 | Earnings Share 2.14 | Revenue Per Share 56.158 | Quarterly Revenue Growth 0.057 |
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.